NVZMY
PINK Novonesis A/S Unsponsored ADR Class B$63.59 ↑ +0.14 (+0.22%) Trading Up from the previous close of $63.45, $0.13 below the day’s high of $63.72
- YTD change
- -0.05%
- vs 20-day SMA
- -4.93%
- vs 200-day SMA
- +2.43%
Price ranges
Price & Performance
+3.70 (+6.19%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 23.7% away from all-time highs of $83.31
- NVZMY is down 0% since the beginning of the year
- NVZMY is up 4% over the past 12 months
- NVZMY is down 11% over the past 1 month
NVZMY reads not so good: price sits above one of the two key moving averages, the 12-month move is +3.8%.
- Previous minute
- +$0.07
- Last hour
- -$0.06
- Last 5 days
- -5.94%
- vs 8-day SMA
- -3.42%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Novonesis (Novozymes A/S) engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.